Medtronic launches MiniMed 780G with Abbott sensor integration, expanding its diabetes ecosystem ahead of a planned spinoff.
Medical Device Network on MSN
Medtronic commercially launches MiniMed 780G with Abbott sensor in US
When used in conjunction with the MiniMed 780G system, the sensor is said to deliver real-time glucose data.
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the ...
Medtronic issues recall diabetes software affecting CareLink version 4.2B due to incorrect glucose data display, prompting clinician review.
Medtronic plc MDT has begun the broad U.S. commercial rollout of the MiniMed 780G system integrated with Abbott’s ABT Instinct sensor, designed exclusively for MiniMed systems. Earlier this year, the ...
Medtronic's diabetes business was a sweet spot in the company's fiscal first quarter of 2024. After FDA approved the company's MiniMed 780G system with the Guardian 4 sensor in April, analysts and ...
Medtronic announced Wednesday that it will spin off its diabetes business into a standalone company. The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, ...
The U.S. Food and Drug Administration says Medtronic's diabetes business is back in compliance. The agency issued a warning letter in December 2021 that detailed concerns about how Medtronic handled ...
Health tech company Medtronic is acquiring insulin patch pump company EOFlow for $738 million, the company announced Thursday. The acquisition is meant to bolster Medtronic’s diabetes offerings and ...
In just the last few years, diabetes technology has grown exponentially smarter. Top of mind now for many devicemakers is the creation of a truly closed-loop system for insulin delivery—a system often ...
Medtronic is the world’s largest pure-play medical device company. It is a dividend aristocrat, conservatively financed and well diversified. It seems like a great long-term investment. The company ...
The Instinct sensor is based on Abbott's most advanced CGM technology and provides real-time glucose readings, which the system uses to automate insulin adjustments every five minutes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results